Axid Articles

OTC drug for heartburn as good a Rx agent costing 10 times more, US study finds

29 January 2007

Dr Reddy's 3rd-qtr net profit falls 11%

9 February 2004

First approvals for generic Axid in USA

15 July 2002

Update: Alkermes to acquire Reliant in $934M deal

1 April 2002

Alkermes to acquire Reliant in $934M deal

25 March 2002

Axid cuts weight gain seen with Zyprexa

8 May 2001

Lilly sells Axid rights to Norgine in European markets

22 November 2000

American Home Pharma Sales Up 7% For 2nd Qtr

22 July 1998

Canadian High Court Slams Drug Laws

21 July 1998

Pharmaceutical Companies Face Up To The Future

15 June 1998

US Quarterly Financial Results Round-Up

23 April 1998

FDA Clears GW's Effervescent Zantac

5 March 1998

Greece To Slim Official Drug List

4 February 1998

UK Planning Product Status Switches

21 January 1998

Australia Excludes SSRIs From Final TGP Scheme

17 December 1997

French Drug Firms Censured Over Promotions

12 August 1997

Generic Ranitidine Finally Reaches US Market

5 August 1997

H2 Blockers' US Sales Boom Set To Slow?

21 October 1996

The Role Of Managed Care In Rx-To-OTC Switches

21 October 1996

AHP Receives Approval For OTC Advil

15 July 1996

Tactical Diversity In The Evolving US Health Market

17 June 1996

Mixed Earnings But Strong Sales For US Companies

12 February 1996

Whitehall-Robins: nizatidine news

9 October 1995

GATT patent extentions for B-M Squibb's Monopril, Lilly's Axid ,

10 July 1995

Weaker US Dollar And Volume Growth Lift 1st Qtr

24 April 1995

Eli Lilly Publishes Letter

27 February 1995

Good Year for Eli Lilly Driven By Prozac

20 February 1995

Glaxo Rumored To Be Eying Eli Lilly

22 August 1994

Benefits From PBM/MPC Acquisitions Assessed

15 August 1994

FDA Warns Lilly Over Axid Claims

1 August 1994

LILLY TO MARKET GENERIC TAGAMET

25 April 1994

RESTRUCTURING CHARGES DEPRESS LILLY AND E KODAK

14 February 1994

UK PRODUCT NEWS IN BRIEF

7 February 1994

US 3rd QTR RESULTS MIXED AS DRUG IND CUTS BACK

25 October 1993

ULCER DRUG MARKET DECLINE FORECAST

4 October 1993

ADVANCES BY US DRUG COMPANIES IN 2nd QTR

26 July 1993

OTC GASTROINTESTINALS IN THE USA

24 May 1993

STUDY ON H2 ANTAGONISTS AND ALCOHOL

12 April 1993

US 4th QTR SHOWS NOT ALL COMPANIES STRONG

15 February 1993

GLAXO TO FILE FOR OTC ZANTAC IN 1994?

1 February 1993

GLAXO AND LILLY'S ULCER DRUGS OFF MEDI-CAL

18 January 1993

US RESULTS 3RD QTR

2 November 1992

STUDY SUPPORTS ULCER/H PYLORI HYPOTHESIS

11 May 1992

Showing 1-43 of 43 articles

Go to beginningPrevious
  • 1
NextGo to end